High Content Screening Market Size, Share, Top Companies, New Technology, Demand and Forecast 2022-2027
According to IMARC Group’s latest report, titled “High Content Screening Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global high content screening market reached a value of US$ 1.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2027, exhibiting at a CAGR of 8.7% during 2022-2027.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
High-content screening (HCS) refers to an analytical approach of automated microscopy that relies on visualization tools to collect quantitative data from cell populations. It is a combination of modern cell biology, flow cytometry, and robotic handling that includes fluorescence imaging to identify the physical and biochemical properties of sample cells. It is extensively used in drug discovery and biological research to identify molecules, such as peptides or RNA interference (RNAi), which can change the phenotype of a cell in the desired manner.
Request Free Sample Report: https://www.imarcgroup.com/high-content-screening-market/requestsample
Market Trends
The growing prevalence of chronic and neurodegenerative disorders, such as Parkinson’s and Alzheimer’s, is catalyzing the need for affordable and effective drug discovery systems. This, in turn, is positively influencing the market. Apart from this, the escalating demand for cost-effective drug discovery systems in the pharmaceutical industry is strengthening the market growth. Moreover, leading manufacturers are focusing on the development of innovative and technologically advanced equipment integrated with artificial intelligence (AI) systems, which is projected to fuel the market growth.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/high-content-screening-market
The report has segmented the market on the basis of product, formulation, application and geography.
Breakup by Product:
- Instruments
- Cell Imaging and Analysis Systems
- Flow Cytometers
- Consumables
- Reagents & Assay Kits
- Microplates
- Other Consumables
- Software
- Services
- Accessories
Breakup by Application:
- Target Identification and Validation
- Primary Screening and Secondary Screening
- Toxicity Studies
- Compound Profiling
- Other Applications
Breakup by End-User:
- Pharmaceutical and Biotechnology Companies
- Academic and Government Institutes
- Contract Research Organizations (CROs)
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific, Yokogawa Electric Corporation, etc.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
